Cystic Fibrosis - PT534

Cystic Fibrosis

No Cure Yet, But Treatment Advances Continue

by Carrie Furberg, BSN, RN, CRN
(4.4 / 3627 ratings )

This course is credentialed for:
Physical Therapy (1.00 Hour(s))

Price: $19.00
CE-PRO Price: $9.50


Cystic fibrosis is an autosomal recessive disease that affects approximately 30,000 children and adults in the U.S. It is a chronic, multisystem disorder that significantly reduces life expectancy. Primary manifestations include progressive obstructive lung disease and pancreatic insufficiency, but patients also may experience chronic sinusitis, nasal polyps, malnutrition, distal intestinal obstructive syndrome, diabetes, liver cirrhosis, pancreatitis, gallstones, and infertility. To have cystic fibrosis, a child must inherit two abnormal cystic fibrosis genes, one from each parent. Each time two carriers have a child, there is a 25% chance the baby will have cystic fibrosis. This module provides updated information on the treatment and management of people with cystic fibrosis.


The goal of this educational program is to provide nurses, physicians, and physical therapists in acute care settings with a deeper understanding of cystic fibrosis and the treatments available, as well as to inform them about the latest research. After taking this course, you should be able to:
  • Describe the basic defect that causes cystic fibrosis and how the disease affects different organ systems.
  • Identify three therapies for the management of pulmonary and gastrointestinal disease in patients with cystic fibrosis.
  • Explain teaching and support responsibilities of clinical personnel for patients with CF and their families.
  • Discuss the status of research into new treatments and potential cures for cystic fibrosis.

Accreditation Information
This course is intended for multiple professions, including nurses, physicians and physical therapists.
Physical therapists: Take this version of the course to ensure you receive appropriate credit.
For the version accredited or approved for another profession, go to your specific profession at or If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at and search for this topic title.
Relias LLC (formerly OnCourse Learning) is an approved sponsor by the New York State Education Department of CE for physical therapists and physical therapist assistants from 6/11/2019 to 6/10/2022.
This activity is provided by the TX Board of PT Examiners Accredited Provider 2202008TX for 02/01/2019 to 02/28/2022 and meets continuing competence requirements for physical therapist and physical therapist assistant licensure renewal in Texas. The assignment of Texas PT CCUs does not imply endorsement of specific course content, products, or clinical procedures by TPTA or TBPTE.
OnCourse Learning is recognized by the Physical Therapy Board of California as an approved reviewer and provider of continuing competency courses for the state of California for 4/5/10 to 12/31/18. Relias LLC is recognized by the Physical Therapy Board of California as an approved reviewer and provider of continuing competency courses for the state of California as of 1/1/2019.
Relias LLC (formerly OnCourse Learning) is a licensed physical therapy continuing education sponsor (#216.000290) with the Illinois Department of Financial and Professional Regulation from October 2018 through September 30, 2020.
This course has been approved as meeting the CE requirements for PTs and PTAs by:
The OH PT Association (approval no. 19S1768 for 7/29/19 to 7/29/20).
The NJ Board of PT Examiners (approval no. 1801-219 for 2/1/18 to 1/31/20).
This course has been approved by:
The MD State Board of PT Examiners for 0.1 CEU for 11/16/19 to 11/16/23.
This course has been approved by the NV State Board of PT Examiners for 0.1 units of continuing education for 12/23/2019 to 7/31/2021.
Other states may accept this course for meeting their CE requirements. Check with your state association or board.
Relias LLC reports completions to the following states utilizing CEBroker: FL, MS, SC, TN (provider # 50-1489).

Course Originally Released on: 11/1/2011
Date of Most Recent Review: 5/7/2020
Course Termination/Update Date: 5/31/2023


Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.


For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.


Reports to CE Broker


Sort By
ROSELLE A - Eastvale, CA  ·  May 21, 2020
It will be better with AV aids.
Was this review helpful?  0
Flora J - Burtonsville, MD  ·  May 21, 2020
this course has a lot of information, added to my knowledge.
Was this review helpful?  0
Linda D - Philadelphia, PA  ·  May 21, 2020
Very informative course.
Was this review helpful?  0
Natalie B - cuyahoga falls , OH  ·  May 06, 2020
very informative learned a lot
Was this review helpful?  0
Lisa W - Dubuque, IA  ·  Apr 14, 2020
Excellent overview of cystic fibrosis.
Was this review helpful?  0
  Page: of 165  
Price: $19.00
CE-PRO Price: $9.50